Melanoma antigen discovery and γδ TCR platform development
PhD student in the Haj Dezfulian laboratory, applying engineering platforms to antigen discovery in melanoma and developing a platform for studying γδ T cell receptors.

MD/PhD student, Immunology Graduate Group
Perelman School of Medicine, University of Pennsylvania
Applying engineering approaches at the molecular and cellular level to develop tools for studying human biology and disease.
Ether Dharmesh is an MD/PhD student in the Medical Scientist Training Program at the University of Pennsylvania's Perelman School of Medicine, with a background in biomedical engineering and research experience spanning biomaterials, drug delivery, and immunology. As a physician-scientist in training, her goal is to connect technology development with fundamental biomedical discovery and translate those insights into new therapeutic approaches.
PhD student in the Haj Dezfulian laboratory, applying engineering platforms to antigen discovery in melanoma and developing a platform for studying γδ T cell receptors.
Nanosilicates added to PEG hydrogel microspheres slow small-molecule release; aqueous two-phase separation keeps the particles injectable. Two further projects: super-lubricious microgels for knee osteoarthritis, and radiopaque microspheres for prostate embolization.
Human stem-cell spheroids encapsulated with magnetic nanoparticles by microfluidics — cells you can sustain, then move and retrieve with a magnet. For targeted regeneration and cryopreservation.
PEG-PCL micelles carrying a VEGFR inhibitor, tested for whether normalizing tumor vasculature first changes the response to subsequent anti-CTLA-4 treatment. The project that connected delivery materials to immunotherapy.
Glad to talk about biomaterials, immunology, or MD/PhD training.
ether.dharmesh@pennmedicine.upenn.edu